Acute myeloid leukemia (AML), an aggressive and often fatal blood cancer, has long resisted a class of drugs called ...
Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most ...
Researchers from the Alliance for Clinical Trials in Oncology have found that two targeted immunotherapy drugs lead to high ...
Leukemia symptoms include fatigue, weakness, chest pain, shortness of breath, bleeding, bruising, and increased infection risk due to altered blood cell counts. Recent leukemia treatment advancements ...
Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex ...
PRESS RELEASE AB SCIENCE PROVIDES INITIAL PHASE 1 DATA FOR THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ...
Advances in leukemia treatment now include targeted drugs, lighter chemotherapy and combination regimens that improve tolerance and reduce resistance. The treatment landscape for leukemia has advanced ...
An international study conducted by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative ...
WICHITA, Kan. (KWCH) - Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate ...
Panelists discuss how social determinants of health significantly impact AML care, particularly regarding transportation ...
Canonization of the Roman Catholic Saint Carlo shines a spotlight on the near cure of acute promyelocytic leukemia — a rare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results